Bayer lobbies for contraceptive access

Aug. 12, 2022

Bayer is lobbying for contraceptive access in the U.S. following the Supreme Court’s recent decision to overturn Roe vs. Wade. 

In a disclosure form shared this week, the company states that it hired the firm Williams & Jensen to work on “issues related to contraceptives,” Medicare policies, drug pricing and more. 

According to Politico, even though Bayer retains nine other outside firms — and employs 11 registered in-house lobbyists — this is the first time the company has explicitly reported lobbying on contraceptive access, according to PI’s analysis of disclosures dating back to 1999. 

The company manufactures some of the most commonly used IUD devices, Mirena, Skyla, and Kyleena. Earlier this year the company announced a $1.53B investment into the expansion of manufacturing operations at its Bergkamen, Berlin, Leverkusen, Weimar and Wuppertal sites in Germany.